Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP are a combination medication used to treat type 2 diabetes. This medication contains 1mg of Glimepiride and Metformin Hydrochloride Prolonged Release. Glimepiride stimulates the pancreas to release more insulin and Metformin Hydrochloride Prolonged Release reduces the amount of glucose produced by the liver, making it easier for the body to use insulin more effectively. The medication is supplied in the form of tablets and is available in a pack of 10x15 tablets. The medication should be taken as per the doctors instructions, and it is recommended to store it in a dry and cool place.